MDxHealth SA (NASDAQ:MDXH) Sees Significant Decrease in Short Interest
by Renee Jackson · The Cerbat GemMDxHealth SA (NASDAQ:MDXH – Get Free Report) saw a significant drop in short interest in January. As of January 15th, there was short interest totaling 25,720 shares, a drop of 34.8% from the December 31st total of 39,441 shares. Approximately 0.1% of the company’s shares are short sold. Based on an average daily volume of 148,347 shares, the days-to-cover ratio is presently 0.2 days. Based on an average daily volume of 148,347 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.1% of the company’s shares are short sold.
Analysts Set New Price Targets
Several analysts recently commented on MDXH shares. BTIG Research reaffirmed a “buy” rating and set a $7.00 price objective on shares of MDxHealth in a research note on Tuesday, December 23rd. Lake Street Capital raised their price target on MDxHealth from $7.00 to $9.00 and gave the stock a “buy” rating in a research report on Thursday, November 13th. Weiss Ratings reiterated a “sell (d-)” rating on shares of MDxHealth in a report on Monday, December 29th. Finally, TD Cowen increased their target price on MDxHealth from $5.00 to $7.00 and gave the stock a “buy” rating in a research note on Thursday, November 13th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $7.75.
Read Our Latest Research Report on MDXH
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the stock. FreeGulliver LLC bought a new stake in shares of MDxHealth during the 2nd quarter worth approximately $273,000. Calamos Advisors LLC acquired a new position in MDxHealth during the third quarter worth $305,000. GSA Capital Partners LLP acquired a new position in MDxHealth during the third quarter worth $48,000. Jefferies Financial Group Inc. bought a new stake in MDxHealth during the third quarter worth $53,000. Finally, Russell Investments Group Ltd. acquired a new stake in MDxHealth in the third quarter valued at $461,000.
MDxHealth Trading Up 0.9%
Shares of NASDAQ MDXH traded up $0.03 during midday trading on Monday, reaching $3.53. The company’s stock had a trading volume of 120,789 shares, compared to its average volume of 145,392. The stock has a 50 day simple moving average of $3.51 and a 200-day simple moving average of $3.64. The stock has a market capitalization of $166.93 million, a price-to-earnings ratio of -5.52 and a beta of 1.64. MDxHealth has a fifty-two week low of $1.35 and a fifty-two week high of $5.33.
MDxHealth (NASDAQ:MDXH – Get Free Report) last released its earnings results on Wednesday, November 12th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.04). MDxHealth had a negative net margin of 30.50% and a negative return on equity of 1,078.01%. The business had revenue of $27.43 million during the quarter, compared to the consensus estimate of $24.11 million. As a group, equities analysts anticipate that MDxHealth will post -1.15 EPS for the current year.
MDxHealth Company Profile
MDxHealth, headquartered in Mechelen, Belgium, with a U.S. presence in Newton, Massachusetts, is a molecular diagnostics company focused on improving the accuracy of cancer diagnosis and treatment decision making through epigenetic biomarker assays. The company specializes in developing and commercializing tests that detect DNA methylation changes associated with urological cancers, enabling more precise risk stratification and patient management.
MDxHealth’s lead product portfolio includes ConfirmMDx and SelectMDx.